OutSmart Cancer - Precision Oncology. Less Guess Work. More Life!

You have probably been told that cancer comes down to a bad gene you inherited, but that is true for only a small slice of patients.My team and I have treated cancer for over 25 years across thousands of patients, and I want to expose what I believe is one of the most overlooked drivers of the disease. In this video I dismantle the idea that cancer has a single cause and show why it is usually a combination of hidden infections, mold and mycotoxins, heavy metals, mitochondrial damage, and an immune system that can no longer see and clear rogue cells. You will learn why only a small percentage of cancers are truly inherited while the majority trace back to epigenetic changes you can actually influence through diet, sleep, stress, toxins, and metabolic health. I pull back the curtain on why standard oncology often stops at a couple dozen markers and a scan, while our approach looks at over a thousand markers, RNA transcripts, DNA mutations, and immune profiling to find where the real targets are. You will walk away knowing the exact questions to bring to your next appointment, from whether you are even on the right chemo to how your team plans to strengthen your immune system and remove the drivers feeding the cancer.To learn more, visit: www.envita.comDisclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

A 2024 paper in the Journal of Cancer Therapy reported a 35-fold improvement in response rates and 88% measurable symptom improvement in late-stage cancer patients treated under a precision oncology protocol, compared to the standard-of-care benchmarks every major cancer center uses. The data was validated by a third-party actuarial firm. After 25 years of treating cancer patients, I did not expect to see numbers like these in print.In this video, I walk you through exactly what the study measured, why the actuarial validation matters more than the headline figures, and what it means if you or someone you love is currently sitting in front of an oncologist.We cover what "standard of care" actually is (and why it is the statistical average, not the ceiling of what is possible), how the study was designed, what a 35x response rate and 88% symptom improvement look like in real patient terms, and the mechanism behind the result: the shift from population-averaged protocols to patient-specific precision oncology based on tumor sequencing and targeted treatment.Most importantly, I lay out the practical next steps. What to ask your oncologist, when to get a second opinion, how to identify a clinic that actually practices precision oncology, and the honest reality about insurance coverage for this kind of care.This is not hype. This is one paper, one cohort, and the strongest real-world evidence we have that the biological ceiling many late-stage patients are told to accept is not actually a ceiling.📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Prevention isn’t just about what you avoid — it’s about how you support your body.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

After 26 years and thousands of cancer patients, most of whom were told elsewhere that nothing more could be done, the lessons that actually changed outcomes are not the ones you hear on morning TV. This is the honest conversation I wish every patient had on day one of their diagnosis.In this video, I walk through the biggest things I've learned about how cancer is actually treated, where the standard system falls short, and what patients and families can do about it. We cover why a diagnosis is not a treatment plan, what "standard of care" really means, and why the phrase "there is nothing more we can do" is usually a policy statement rather than a medical one. I explain why most tumors have never been properly tested at a genetic and molecular level, the root causes hiding in plain sight, and how the gut, nutrient deficiencies, and the overall state of the body shape how well any treatment works.Then I shift to what you can actually do: when to get a second opinion (hint: much earlier than most people think), the exact questions to ask your oncologist, and why the caregiver is the second patient in the room. I close with the case that changed what I believed was possible, a late-stage patient who has been in remission for 25 years.Whether you are facing cancer yourself, walking alongside someone who is, or simply trying to stay informed, this is meant to give you clarity and real options.📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Prevention isn’t just about what you avoid — it’s about how you support your body.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Are you eating to lose weight, or are you eating to rebuild the terrain that cancer hates?Visceral belly fat is not passive storage, it behaves like active endocrine tissue that drives the inflammation and insulin resistance linked to cancer growth and recurrence, which is why I stopped treating the number on the scale as the real goal a long time ago. I am Dr. Dino Prato, founder of Envita Medical Centers, and for 25 years my team and I have helped thousands of cancer patients who had already exhausted the top cancer hospitals in the country, using precision testing and custom built immunotherapy. In this episode I break down the 10 metabolic foods I use to lower energy density without starvation, feed a resilient microbiome, and give the immune system what it needs to recognize abnormal cells.I will show you why high water, high fiber, high phytochemical foods stretch your stomach receptors and create a natural satiety response, backed by a 2022 systematic review showing lower energy density produces larger sustainable reductions in daily intake. I walk you through watermelon and its lycopene and citrulline, cucumbers and the apoptosis research, celery as a source of apigenin, arugula and the cruciferous compounds the National Cancer Institute links to carcinogen inactivation, eggs for protein and choline with muscle as a glucose sink, zucchini noodles as my low glycemic pasta swap, psyllium husk and the 2023 meta analysis on body weight, fermented foods for microbiome diversity, berries for anthocyanins and oxidative stress, and broccoli and Brussels sprouts for sulforaphane. I also give you the exact plate order I recommend, the pre meal drink and 10 to 20 minute wait, the interval walk after eating, and the five questions I want you asking at your next oncology appointment covering fasting insulin, A1C, immune profiling, inflammatory markers, gut microbiome, and muscle mass. If you do not have much appetite, I tell you plainly that you need nutrient dense calories instead, and I want you working with your doctor before you change anything.To learn more, visit: www.envita.comDisclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

🧬 About Dr. Dino Prato and Envita Medical CentersMy life's work at Envita Medical Centers has been a mission to help patients find hope when they've run out of options. As a pioneer in precision personalized medicine, I founded Envita Medical Centers to offer next-level care. We use state-of-the-art testing and treatments that are not only data-driven but also precisely targeted to each individual.By the grace of God, we've been able to help many families. Our approach isn't about treating a disease; it's about treating a unique person and providing a custom blueprint for healing. We believe every life is precious and unrepeatable, and we approach each patient with the love and dignity they deserve. The message we give them is one of life and hope. 📍 Envita Medical Centers – At Envita Medical Centers in Scottsdale, AZ, we believe in a radical, loving approach to patient care. Our unique campus is home to a dedicated team of over 400 professionals, including doctors (MD, DO, NMD), pharmacists, nurses, and researchers, all working together in a seamless ecosystem.To learn more, visit: www.envita.comDisclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

I'm Dr. Dino Prato, founder of Envita Medical Center, and after 25 years treating thousands of patients, including many who were told there was nothing left to be done at top hospitals, I wanted to sit down and talk about what actually drives cancer risk, the part most people never get explained to them in a normal doctor's visit.In this one I break down what I call the fastest way to get cancer in 2026, not because anyone wants that, but because when you understand what stacks the deck against you, you understand what to remove. The truth is cancer usually doesn't appear out of nowhere. It's rarely one villain. It's the combination, the metabolic dysfunction, poor sleep, chronic toxic load, chronic stress, gut damage, and a sedentary lifestyle all piling up year after year until the body's terrain turns against you.I walk through all six, why each one matters, and the simple daily changes that move the needle on every one of them. Then at the end I share the specific tools I actually use with patients to help the body repair and heal, the building blocks for reducing inflammation, restoring your cell membranes, and strengthening immunity, plus why deep testing and modern cancer screening matter even for people who seem to be doing everything right.Because some people do everything right and still develop cancer, and that's usually because nobody looked deep enough to find the real root cause.Before you change anything, work with a good doctor. This video is for education, not a substitute for personal medical care.To learn more, visit: www.envita.comDisclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

I'm Dr. Prato, and after 26 years treating cancer at Envita with patients flying in from over 50 countries, I wanted to sit down and talk about what I actually believe is the real cause of cancer, the one most people never get explained to them in a normal doctor's visit.In this one I break down why the accepted list, genetics, smoking, diet, bad luck, isn't wrong exactly, but points the whole conversation in the wrong direction, and why so many people who do everything right still end up with a diagnosis nobody can explain.To learn more, visit: www.envita.comDisclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

In this video I'll be covering all of the most important lessons and information I've learned through 26 years of cancer research and experience in the field.📍 Envita Medical Centers – At Envita Medical Centers in Scottsdale, AZ, we believe in a radical, loving approach to patient care. Our unique campus is home to a dedicated team of over 400 professionals, including doctors (MD, DO, NMD), pharmacists, nurses, and researchers, all working together in a seamless ecosystem.To learn more, visit: www.envita.comDisclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Most cancers are caught late, not because the body wasn't trying to warn you, but because the early signs get blamed on something else. By the time someone takes it seriously, the cancer has had a year, sometimes two, to get a head start.I'm Dr. Prato. I've spent 26 years treating cancer at Envita across hundreds of patients.In this video I'm walking through the early signs of cancer that most people overlook, why each one tends to get dismissed, and the specific moment to stop waiting and get checked.You'll get each sign paired with the misattribution that usually buries it (the fatigue blamed on stress, the change in habit blamed on age, the symptom blamed on diet) and a clear 'when to act' line so you know exactly when something is worth mentioning at your next appointment.📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Prevention isn’t just about what you avoid — it’s about how you support your body.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Cutting sugar to starve a tumour is the most repeated cancer-diet advice on the internet. After 26 years treating patients from over 50 countries at Envita, Dr. Prato thinks it's also one of the most misunderstood.This video walks through what actually drives the link between diet and cancer, why two people can eat the exact same meal and have completely different metabolic outcomes, and the lever that almost nobody talks about because it isn't visible on the plate. You'll see how insulin, IGF, and chronic inflammation create the conditions cancer cells actually thrive in, what a clean diet on paper can hide in the bloodwork, and the markers a sharper doctor would run alongside a standard panel.By the end you'll have a tighter mental model, a specific list of tests to ask for, and a few practical levers you can move once your own physician signs off. Nothing here replaces a conversation with your own doctor, especially anyone in active treatment.📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Prevention isn’t just about what you avoid — it’s about how you support your body.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

This video discusses the critical issue of cancer treatment heterogeneity, where the same cancer type and stage can present with different markers. This often leads to patients receiving ineffective medications, highlighting a crisis in cancer therapy. Deeper analysis, using advanced techniques like next generation sequencing, could identify the correct targeted therapy and improve patient outcomes. Understanding what is cancer at the genetic level is crucial for effective care.🎯 What You’ll Learn in This Episode• Why cancer treatment may not be one-size-fits-all• What tumor heterogeneity means• The role of DNA and RNA testing• Why immune system considerations matter• How treatment decisions are made• What questions to ask your oncologist• Why deeper data may influence care• How personalized approaches are evolving📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“The right questions can help you better understand your treatment options.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

This video discusses the critical role of the immune system in treating solid tumors, suggesting it's a key breakthrough not widely offered to many a cancer patient.Dr. Dino Prato highlights that the immune system's ability to uniquely target and destroy cancer cells makes it superior to conventional drugs, emphasizing the need for advanced cancer therapy and patient care. We discuss why a precision medicine approach, focusing on immunology, is essential for effective cancer care.🎯 What You’ll Learn in This Episode• Why the immune system is important in cancer care• What immunotherapy does• Why some tumors evade immune detection• The role of neoantigens and immune signaling• How different immune cells interact• Why responses to immunotherapy vary• The difference between blood cancers and solid tumors• How personalized approaches are being explored📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“The immune system doesn’t just fight cancer — it learns how to find it.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Many cancer patients feel scared and overwhelmed after appointments, often seeking help online.This video explores the dangers of misinformation in cancer therapy, highlighting how some advice, while seemingly helpful, can be harmful. It emphasizes the critical need for reliable health advice and comprehensive patient education to ensure proper patient care. 🎯 What You’ll Learn in This Episode• What tele-oncology is and how it’s used• Why some programs may lack clinical depth• The difference between navigation and clinical decision-making• Why deeper testing may matter in cancer care• How to evaluate cancer guidance programs• What “precision oncology” should actually include• Why monitoring matters beyond imaging• Questions to ask before trusting a program📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Not all guidance is equal — the right questions can protect your care.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

This episode explores how fear can dominate the mind during cancer treatment, emphasizing the importance of a positive mindset for healing.We discuss the biological impact of chronic anxiety and how taking control of your mental health can significantly affect outcomes. This inspirational video offers insights into achieving the right mindset and embracing positive thinking to support your journey.🎯 What You’ll Learn in This Episode• How fear and stress affect the body biologically• The role of cortisol and inflammation• Why sleep and mental health matter in recovery• The connection between mindset and immune function• Practical ways to manage stress• The importance of community and support• Why emotional health is part of whole-body care• How mindset fits into a broader treatment strategy📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Your mindset doesn’t replace treatment — but it can influence how your body responds.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Our latest discussion highlights the critical role of seed oils in cancer progression, using a stage three colon cancer patient as a case study.Despite standard cancer treatment, her cancer showed recurrence, prompting a deeper look into her metabolic health and gut health. We explore how factors like inflammation in the body and a dysbiotic gut microbiome can significantly influence patient outcomes, emphasizing the need for a holistic approach to nutrition and healthy eating.🎯 What You’ll Learn in This Episode• The difference between seed oils and oxidized fats• What lipid peroxidation means• How cooking methods affect oil stability• Why heat, light, and storage matter• The connection between gut health and immunity• How inflammation impacts the body• Which fats are more stable for cooking• Practical ways to reduce oxidative stress in your diet📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“It’s not just what you eat — it’s how it’s processed, stored, and cooked.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

After a woman finishes her breast cancer treatment and is ringing the bell, a quiet concern often remains: the possibility of recurrence. Even after successful cancer treatment, early-stage breast cancers can return in 30% of cases. This video aims to provide essential patient education for any cancer patient facing this reality, emphasizing the need for continued vigilance in oncology.🎯 What You’ll Learn in This Episode• Why breast cancer can return after treatment• What “watch and wait” typically means• The difference between early-stage and metastatic disease• Why tumor biology varies between patients• The role of immune function in cancer care• What deeper testing may include• Why monitoring matters beyond imaging• How to think about long-term survivorship📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Finishing treatment isn’t the end — it’s the beginning of long-term strategy.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

This episode explores challenging medical prognoses, from inoperable tumors to dire timelines, highlighting the critical need for advanced patient care.Dr. Prato discusses how precise oncology approaches can offer hope, even when traditional healthcare options seem limited. By focusing on personalized cancer treatment, we aim to redefine what's possible for every cancer patient.🎯 What You’ll Learn in This Episode:• What “2–3 months to live” typically means clinically• Why cancer varies between patients• The role of deeper biological testing• What multi-omics analysis includes• Why monitoring between scans matters• The concept of immune-focused treatment strategies• 5 key questions to ask your doctor• How treatment planning may evolve over time📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“When cancer is complex, decisions should be guided by deeper data — not just timelines.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

When a 52-year-old woman experienced breast cancer recurrence after initial radiation therapy, her oncologist considered a stronger chemotherapy regimen. However, her compromised immune system and high inflammation in the body indicated a need for a different approach.In this episode, Dr. Prato focuses on performing a root cause analysis to address these deeper issues, moving beyond just cancer treatment.🎯 What You’ll Learn in This Episode:• Do root canals cause cancer?• How oral infections may impact immune function• What microleakage means in dentistry• Why some infections go unnoticed• The connection between inflammation and cancer• Signs of possible oral health issues• Why proper dental evaluation matters• How oral health fits into a broader care strategy📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“The mouth is not separate from the body — it’s part of the immune system.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Ever wonder why you feel tired even after a full night's sleep?This episode explores the vital connection between what we eat and our energy levels, especially for those undergoing cancer treatment. Dr. Prato highlights how proper nutrition and healthy food choices act as "food as medicine" to support mitochondrial health, the true "powerhouse of the cell," ultimately helping to boost energy and promote a more vibrant, healthy lifestyle.🎯 What You’ll Learn in This Episode:• Why mitochondria are important in cancer care• How energy production affects recovery and resilience• The role of diet in supporting cellular function• 7 foods that may support mitochondrial health• Why gut health and immunity are connected• The impact of inflammation on energy levels• Why consistency matters more than perfection• How nutrition fits into a broader treatment strategy📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Energy at the cellular level supports resilience at the whole-body level.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

This episode critically examines the conventional approach to cancer treatment, suggesting that current health care strategies often resemble playing 'checkers' against a 'chess' opponent.Dr. Dino Prato points out the significant mistake in applying a 'one-size-fits-all' medicine for advanced oncology cases, where standard regimens are tried sequentially. The discussion emphasizes how this approach can lead to patient weakening before clinical trials or personalized solutions are considered, highlighting the need for a more strategic perspective in medical care.🎯 What You’ll Learn in This Episode:• Why cancer is compared to chess, not checkers• How tumors evolve and adapt over time• Why standard treatment sequences may fall short in complex cases• What deeper biological testing can reveal• The role of tumor microenvironment and immune response• Why strategy matters in advanced cancer care• The importance of individualized treatment planning• Questions to ask your doctor about treatment strategy📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Cancer adapts — so treatment must be strategic, not reactive.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Dr. Dino Prato discusses custom-building immunotherapy, highlighting its limitations and potential for patients with stage four melanoma.He explains that treatments like Keytruda only work long-term for a small percentage of patients and that many are not candidates due to "cold" tumors, an important aspect of modern oncology. Dr. Dino Prato explores how advancements in immunotherapy for cancer are shaping the future of cancer treatment, emphasizing the role of the immune system in fighting the disease. 🎯 What You’ll Learn in This Episode• Why immunotherapy doesn’t work for all patients• What checkpoint inhibitors actually do• The role of immune signaling in cancer response• Why tumor biology differs between patients• What “cold tumors” mean• How tumor microenvironment affects treatment• Why deeper testing is being explored• How personalized approaches may guide care📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Immunotherapy isn’t one-size-fits-all — it depends on how your immune system and tumor interact.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Dr. Prato explores a critical reason why immunotherapy for cancer often falls short: T-cells and other immune cells can't reach the cancer cells.He details a phenomenon where crucial t lymphocytes are blocked from entering tumors, preventing them from doing their job. Understanding this challenge in immunology is key to advancing effective cancer treatment strategies.🎯 What You’ll Learn in This Episode• What T-cell exclusion means• Why immune cells may be blocked from tumors• What “cold tumors” really are• How tumor microenvironment affects treatment response• The role of CXCR4 and CXCL12 signaling• Why immunotherapy doesn’t work for every patient• How immune positioning impacts outcomes• Why personalized approaches are being explored📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Sometimes the immune system isn’t weak — it’s locked out.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

In January 2026, the American Cancer Society announced a 70% cancer survival rate, a statistic that can be misleading to a cancer patient.Dr. Prato clarifies the nuances behind this data, emphasizing that while there's progress, it largely reflects early-stage disease and not late-stage cancers. Understanding the true incidence and context of these statistics is vital for public health and effective cancer treatment.🎯 What You’ll Learn in This Episode• What the 70% cancer survival statistic represents• Why early-stage cancers influence overall survival numbers• How metastatic cancer differs biologically• Why survival rates vary by cancer type and stage• The role of early detection in improving outcomes• How deeper testing may guide treatment decisions• Why individualized approaches are gaining attention• Questions to ask when reviewing cancer statistics📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Statistics describe populations — but your treatment should be based on your biology.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

In recent celebrity news, Disney star Christy Carlson Romano faced a significant hurdle after a positive cancer screening, highlighting the challenges many encounter. Her struggle to get a necessary PET/CT Scan approved by health insurance underscores a broader issue within medical insurance systems. This incident brings to light the importance of early cancer detection and raises questions about equitable access to care, even for those in the public eye.🎯 What You’ll Learn in This Episode• What a positive cancer screening test actually means• The difference between a signal and a diagnosis• The role of imaging after early detection• Why biopsy is required for confirmation• What circulating tumor cells and molecular tests show• Why some patients face delays in follow-up care• How early detection may change outcomes• Questions to ask your doctor after a positive test📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Early detection is only powerful if you know what to do next.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Six hundred thousand Americans will die from cancer this year, but many of these deaths are preventable.Dr. Prato highlights that early detection and new approaches to cancer prevention could drastically improve outcomes and reduce mortality. We explore the importance of holistic health and effective treatment strategies in oncology to ensure fewer lives are lost to this disease.🎯 What You’ll Learn in This Episode• What the “40% of cancers are preventable” statistic means• Key lifestyle and environmental risk factors• The role of infections in cancer risk• Why early detection improves outcomes• What multi-cancer early detection (MCED) tests are• How metabolic and immune health influence cancer risk• The difference between prevention and treatment strategies• Why individualized approaches are becoming more important📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Prevention and early detection may change the trajectory of cancer care.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

A new device has received food and drug administration approval for pancreatic cancer, offering a new tool in cancer treatment. This wearable technology works by disrupting cancer cells, potentially slowing growth. While not a cure, this development in medical research provides a valuable addition to oncology strategies, buying time for patients.🎯 What You’ll Learn in This Episode• What Tumor Treating Fields actually are• How the Optune device works• Why pancreatic cancer is difficult to treat• Why slowing tumor division may buy valuable treatment time• The limitations of IV chemotherapy delivery to pancreatic tumors• Why immune activation is critical for long-term response• How multi-omics testing identifies personalized targets• Why new technologies should be combined with precision strategies📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“New technology can slow cancer — but long-term control often depends on activating the immune system.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

In early 2026, social media buzzed with claims of a 100% success rate for free cancer vaccines, raising hopes for patients eager for a medical breakthrough.This news highlights how cancer treatment can become a tool in geopolitics and global politics, as nations vie for influence. It's crucial to understand these social media trends and approach such information with critical thinking.🎯 What You’ll Learn in This Episode• Why viral “100% cure” headlines spread so quickly online• The difference between early research and clinical treatment• How cancer vaccines and mRNA therapies are being studied• Why cancer remains biologically complex and individualized• What multi-omics testing means in oncology• Why tumor genetics and immune markers matter• How precision oncology evaluates treatment options• Why patients should evaluate headlines carefully before making treatment decisions📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Cancer headlines move fast — but treatment decisions should always be guided by data.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Dr. Prato explores the promising field of peptide therapy, highlighting how these powerful compounds can contribute to healthy aging and overall wellness.We discuss the potential for peptides to support joint health and bone health, offering a new perspective on maintaining physical vitality. The research also suggests benefits for brain health, making peptides a fascinating area of study for those interested in anti-aging strategies.🎯 What You’ll Learn in This Episode:- What peptides actually are- Why timing matters during chemotherapy- Which peptides may stimulate growth pathways- Which peptides may support immune signaling- The risks of black-market peptide sourcing- Why diet, sleep, and gut health come first- How precision oncology integrates immune support safely- The importance of physician supervision📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Peptides don’t heal chaos — they amplify signals. Make sure the signal is the right one.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Cancer treatment can profoundly affect intimacy and marital connection, often leading to challenges in sexual health and relationships. Many couples face issues like decreased sexual function and confidence after chemotherapy, yet these challenges are not insurmountable.Dr. Prato provides practical marriage advice and integrative tools to help navigate these impacts, offering hope and solutions for a fulfilling connection post-treatment.🎯 What You’ll Learn in This Episode:- Why cancer treatment affects libido and performance- The role of sleep and cortisol in sexual health- When bioidentical hormones may be appropriate- Safe considerations for testosterone microdosing- When localized estriol therapy may be considered- The role of circulation in erectile function- Natural nitric oxide support strategies- Why emotional connection matters just as much as biology📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Intimacy is not lost after cancer — it must be rebuilt with wisdom, patience, and the right support.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

When a loved one faces metastatic cancer, the outlook can be challenging, with significantly low survival rates for conditions like lung cancer and breast cancer. Dr. Prato highlights the stark reality of cancer cells spreading, contrasting the American Cancer Society's optimistic 70% overall survival rate with the grim statistics for a cancer patient with advanced disease. Understanding the nuances of cancer treatment and its efficacy against metastasis is crucial.🎯 What You’ll Learn in This Episode• What the “70% cancer survival” statistic actually represents• Why early-stage and metastatic cancers have very different outcomes• Why stage-specific survival data matters for patients• How early detection dramatically improves outcomes• What multi-cancer early detection testing is• How multi-omics testing helps guide treatment decisions• The role of immune profiling in cancer treatment strategies• Why personalized oncology approaches are growing in importance📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Cancer statistics describe populations — but treatment decisions must focus on the individual.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Many cancer patients face a dual challenge: battling the tumor and an invisible enemy—infections from mold and mycotoxins. Dr. Prato explores how water-damaged buildings can harbor toxic mold, often overlooked by standard oncology practices. We highlight the critical need to address environmental health factors like mold exposure as potential root causes, ensuring comprehensive patient care alongside traditional cancer treatment. 🎯 What You’ll Learn in This Episode:- The difference between mold spores and mycotoxins- How mold exposure can stress the immune system- What CIRS (chronic inflammatory response syndrome) means- Why inflammation complicates cancer recovery- The role of binders and detox support (under medical care)- What MARCoNS biofilm infections are- Why immune balance (TH1/TH2) matters- The right questions to ask about mold testing📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“You can’t rebuild immunity while something is quietly breaking it.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

A Spanish research team achieved remarkable results, making pancreatic cancer tumors disappear in mice by targeting multiple escape routes simultaneously. This approach prevented tumor recurrence and resistance, highlighting a design strategy central to precision cancer medicine.Dr. Dino Prato discusses how this mirrors the principles of targeted cancer therapy, emphasizing the importance of understanding the tumor microenvironment for effective cancer care.🎯 What You’ll Learn in This Episode:- Why pancreatic cancer is so difficult to treat- What KRAS, EGFR, and STAT3 do- How tumors develop resistance- What the triple-lock strategy means- Why mouse data doesn’t always translate to humans- The difference between one-size-fits-all and precision oncology- Why immune activation matters for long-term control- Questions to ask your doctor about pathway targeting📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Cancer adapts — so treatment must adapt faster.”DisclaimerThis podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or impliedOutcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Many people don't consider that cancer might be a 'power plant problem' rather than just a tumor issue. Dr. Prato explores how mitochondrial damage and its impact on energy production can lead to symptoms like fatigue, brain fog, and immune weakness. Understanding cellular health and metabolic health is crucial, as mitochondrial dysfunction can be a key driver of various diseases, including chronic fatigue syndrome.🎯 What You’ll Learn in This Episode:- Why mitochondria matter in cancer biology- The link between metabolism and immune function- How toxins and infections damage mitochondrial DNA- What methylene blue does in the electron transport chain- Why timing matters during chemotherapy- The role of CoQ10, NADH, and D-ribose in ATP production- How to support detox and redox balance- Why mitochondrial health influences long-term remission📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Energy isn’t just about feeling good — it’s about cellular survival.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Dr. Dino Prato discusses the crucial role of nutrition in cancer treatment, emphasizing that a truly healthy eating approach goes beyond just adding superfoods.He highlights the importance of removing foods that sabotage the immune system, explaining how this strategy is foundational to effective cancer treatment. Understanding "food as medicine" is key to supporting the body's defenses and acting as an immune system booster. 🎯 What You’ll Learn in This Episode:- The first foods to eliminate from an anti-cancer diet- Why gut microbiome health is critical- How fatty fish and olive oil reduce inflammation- The immune role of beta-glucans from mushrooms- Why cruciferous vegetables support detoxification- The benefits of berries and polyphenols- How green tea (EGCG) supports immune balance- Why sustainable Mediterranean-style eating works long-term📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Cancer care isn’t just about killing cells — it’s about strengthening the terrain.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

A new Georgia bill allowing over-the-counter ivermectin has ignited debate about medical ethics and individual freedom of choice. This news highlights a deeper concern: cancer treatment options for patients who feel they have no alternatives.We explore the implications for public health and medicine when patients seek solutions outside conventional care. 🎯 What You’ll Learn in This Episode• What Georgia’s ivermectin bill actually proposes• Why ivermectin is being discussed in cancer research• Why ivermectin is not an FDA-approved cancer treatment• The risks of self-medicating with repurposed drugs• How pathways like PI3K, mTOR, and STAT3 relate to tumor biology• Why repurposed drugs must be target-driven• The role of combination therapy in oncology• How precision oncology evaluates off-label treatments safely📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“The right drug, the right target, the right time — that’s precision oncology.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Drawing from 25 years of clinical experience, Dr. Prato discusses methods to greatly reduce cancer risk and how to prevent cancer. This video highlights the importance of choosing a good doctor and understanding effective cancer care strategies. We emphasize that prevent cancer is a goal we strive for with every patient at our medical clinic. 🎯 What You’ll Learn in This Episode:- Why immunity is the first and last defense against cancer- The 5 foundational pillars of immune resilience- How metabolic dysfunction increases cancer risk- The importance of vitamin D, zinc, and beta-glucans- Why gut health influences 70% of immunity- What multi-cancer early detection testing is- How to approach early signals without panic- The difference between standard screening and precision screening📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Prevention isn’t luck — it’s preparation.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Some cancers can progress rapidly, even in weeks, often outpacing conventional drug treatments. This video highlights the critical need for proper testing and targeted cancer therapy to address these aggressive forms of cancer. We explore how gene mutations, specifically dna amplification, can accelerate cancer growth and adaptation, emphasizing the role of precision medicine in developing effective cancer treatment strategies.🎯 What You’ll Learn in This Episode:- What chromothripsis is and why it matters- How gene copy amplification accelerates cancer growth- Why some cancers adapt rapidly to treatment- The link between inflammation and resistance- How immune suppression enables aggressive tumors- Why standard testing may miss key drivers- The role of RNA transcriptomics and spatial biology- The right questions to ask about deep cancer testing📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Fast-growing cancer isn’t always stronger — it’s often smarter. And smart problems require precision solutions.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Cancer recurrence often stems from dormant cancer cells, not just the primary tumor. These "sleeper cells" can reawaken years later, leading to metastasis.This video presents a smarter approach to cancer treatment, focusing on preventing recurrence after remission using off-label drugs and integrative agents.🎯 What You’ll Learn in This Episode:- Why cancer recurrence often begins with dormant cells- What micrometastatic disease means- How mTOR fuels cancer regrowth- How autophagy helps cancer survive under stress- The role of off-label repurposed medications- Natural compounds that influence growth pathways- Why zinc and vitamin D matter for immune function- The right questions to ask your doctor after remission📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Remission is not the end of treatment — it’s the beginning of prevention.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Moderna — the company that became a household name during the global pandemic — is now attacking cancer treatment with personalized mRNA technology in the form of a melanoma immunotherapy vaccine. But does their research hold up?🎯 What You’ll Learn in This Episode:- What Moderna’s mRNA melanoma vaccine does- How neoantigen vaccines are created- Why Keytruda is used in combination- What a 49% recurrence reduction actually means- The role of tumor heterogeneity- Why cold vs hot tumors matter- How tumor microenvironment impacts response- Differences between synthetic vaccines and direct tumor immunotherapy📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“The future of cancer care isn’t one-size-fits-all — it’s immune-informed precision.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at:https://www.scirp.org/journal/paperinformation?paperid=132493

Pancreatic cancer is one of the toughest cancers in the world — not just because of its location, but because of the stromal barriers that block chemotherapy from reaching the tumor. Most IV chemo delivers less than 1% of the drug to the cancer itself. The result: months of toxicity with very little benefit.In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, explains how precision oncology breaks through that wall using deep multi-omics mapping (DNA, RNA, immune, and spatial biology), combined with 3D cone-beam interventional oncology to deliver therapy directly inside the pancreatic tumor. Instead of relying on massive surgeries like the Whipple — with complication rates up to 60% — precision care uses a catheter the size of a hair to deliver genetically targeted chemotherapy, immunotherapy, and nanoparticle-based agents exactly where they are needed. This approach kills the tumor locally and stimulates a systemic immune response throughout the body.Dr. Prato also explains how microdosed systemic therapy, NK and dendritic cell immunotherapy, phytotherapeutics, and real-time monitoring with ctDNA, CTCs, and methylation scores help treat micrometastatic disease while preserving quality of life.🎯 What You’ll Learn in This Episode:• Why pancreatic cancer blocks most chemotherapy• How stromal barriers and high-pressure tumors make standard care fail• What 3D cone-beam, catheter-based targeting really looks like• The role of DNA, RNA & immune spatial biology in mapping treatment• How microdosed systemic chemo kills micrometastatic cells with fewer side effects• Why NK cells, dendritic cells & DAMP signaling matter for long-term control• How precision monitoring keeps treatment effective in a fast-mutating cancer📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak to a care coordinator: 866-830-4576Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

This episode discusses the serious implications of Lyme disease, especially cases that remain undiagnosed, highlighting its connection to autoimmune diseases and cancer.We explore recent research, specifically a 2024 study that found "borrelia burgdorferi" DNA in invasive breast cancer cases, emphasizing the critical need for proper "Lyme disease testing". Understanding the role of the "immune system" and accurate "disease education" is vital for effective "cancer therapy" and overall "health" management.🎯 What You’ll Learn in This Episode:- Why Lyme disease is frequently missed- What “chronic Lyme disease complex” really means- How co-infections suppress immunity and drive inflammation- The link between infections, autoimmunity, and cancer recurrence- Why false-negative Lyme tests are common- How neuroborreliosis affects the brain and nervous system- Why infections must be treated before repair and recovery- The right questions to ask your doctor about testing📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“You can’t rebuild the immune system until you remove what’s breaking it.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

This video explains why blood cancer can recur, often due to minimal residual disease (MRD) that goes undetected despite initial treatment success.We discuss how initial improvements in scans and blood counts can be misleading, as unseen disease may persist and lead to relapse. Understanding this is crucial for effective blood cancer treatment and preventing future challenges.🎯 What You’ll Learn in This Episode:- What minimal residual disease really is- Why remission alone isn’t enough in blood cancers- How MRD causes relapse months or years later- The difference between transplant vs short-term immune strike- How borrowed donor immune cells can target MRD- Why timing matters (not for active blast crisis)- How MRD can be tested and monitored- The questions to ask your doctor after remission📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Relapse doesn’t start big — it starts with what was left behind.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

In this episode, Dr. Dino Prato navigates the complexities of treating cancers that appear invisible to the immune system, making traditional immunotherapy for cancer less effective. He explains how building custom immunotherapies and changing tumor information can overcome these limitations, offering new avenues for cancer treatment. This discussion is crucial for anyone interested in advancements in oncology and how precision oncology is shaping the future of care, focusing on immune responses.🎯 What You’ll Learn in This Episode:- What “cold tumors” really mean- Why KRAS drugs slow cancer but rarely finish it- What microsatellite stability actually tells doctors- Why PD-1 inhibitors fail most patients long-term- How precision oncology turns cold tumors hot- The role of spatial biology and immune mapping- Why direct-to-tumor therapy releases immune targets- The right questions to ask when told “nothing else can be done”📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Cancer isn’t beaten by managing it — it’s beaten when the immune system can finally see it.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

This video clarifies why the common advice to "eat whatever you want" during cancer treatment is misleading, emphasizing that food provides crucial signaling for your body.We explore how nutrition impacts your immune system, shapes your gut health, and plays a vital role in reducing inflammation and cancer progression. The Mediterranean diet, highlighted by research, offers significant benefits for overall health and fighting cancer, demonstrating how foods that fight cancer can be integrated into a healthy diet.🎯 What You’ll Learn in This Episode:- Why food acts as immune and metabolic signaling- How the Mediterranean diet supports cancer outcomes- Why gut microbiome diversity matters for immunity- The difference between ancient vs modern Mediterranean diets- Why ultra-processed foods drive inflammation and disease- How to build a sustainable, lifelong anti-cancer diet- How to combine Mediterranean eating with fasting strategies- Practical food examples that support immunity and energy📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Food is your first immune therapy — if you choose it wisely.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Dave Coulier, known for his role as Uncle Joey, shares his public battle with oral cancer. His journey included 35 rounds of radiation oncology and robotic surgeon, highlighting how outdated care can be even for those with access to top hospitals.Our aim is to help patients in their cancer treatment and maintain remission, focusing on effective strategies for head and neck cancer.🎯 What You’ll Learn in This Episode:- What squamous cell carcinoma of the tongue is- Why head and neck radiation can affect quality of life- The potential immune links between lymphoma and other cancers- How viral infections relate to immune suppression- What deep multi-omics testing reveals- How precision immunotherapy differs from standard protocols- Why early adaptive monitoring matters- Questions to ask before starting treatment📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Cancer treatment should not only aim for survival — but preserve the life you’re living.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Anktiva is an exciting new cancer immunotherapy that helps the immune system fight and kill cancer cells. Doctors believe it could support treatment for many cancers when used in the right personalized combinations — but what is it really, and why won’t it work the same way for every patient?In this episode of Outsmart Cancer, Dr. Dino Prato breaks down the science, the hype, and the clinical reality behind Anktiva, an FDA-approved IL-15 super agonist cytokine currently indicated for invasive bladder cancer.Unlike many targeted cancer drugs that only slow disease, Anktiva is designed to activate the immune system — particularly natural killer cells and CD8 T cells — with the goal of cytotoxic tumor kill. But immune stimulation alone is not enough.Dr. Prato explains why immunotherapies like Anktiva require the right tumor information to be effective. Without exposing tumor antigens, neoantigens, and damage-associated molecular patterns (DAMPs), even powerful immune activators may produce only short-term responses.This episode explores how precision oncology integrates deep DNA sequencing, RNA transcriptomics, immune profiling, and spatial biology to identify the right patients, pathways, and combinations. Dr. Prato outlines how direct-to-tumor strategies, micro-dosing, off-label use, and immune-supportive phytotherapeutics can transform Anktiva from a single drug into part of a coordinated immune attack.🎯 What You’ll Learn in This Episode:- What Anktiva is and how IL-15 immunotherapy works- Why immune stimulation alone doesn’t guarantee success- The role of NK cells, CD8 T cells, and immune memory- Why tumor information must be released for immunotherapy to work- How precision testing guides on- and off-label use- Why plasma exchange may be necessary during strong immune responses- How combination strategies outperform single-agent therapy📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

This video addresses a common patient fear: whether a biopsy might lead to cancer spread.We provide honest data and health education, explaining that while biopsy-related seeding is real, the information gained through procedures like lung biopsies is critical for early detection and treatment. Our aim is to empower you with health tips to make informed decisions without hype or false reassurances.🎯 What You’ll Learn in This Episode:- Whether biopsies can really spread cancer- How rare biopsy-related seeding actually is- Why technique matters more than the needle- What the coaxial needle technique is and why it’s safer- The role of liquid biopsies and circulating tumor cells- When biopsy risk is already irrelevant due to existing spread- Why deep molecular and immune testing matters more than fear- The right questions to ask before agreeing to a biopsy📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Good data saves lives. Fear delays answers.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

It is now believed that the average person carries the equivalent of a spoonful of microplastics inside their body — with emerging research suggesting significant accumulation in organs such as the brain.Yet despite growing scientific concern, microplastics remain largely ignored in conventional cancer care.In this episode of Outsmart Cancer, Dr. Dino Prato explains how microplastics function as invisible internal contaminants that drive chronic inflammation, oxidative stress, immune suppression, and genetic instability — all of which create conditions that allow cancer to grow, spread, and resist treatment.Dr. Prato explores how microplastics interfere with tumor-suppressive pathways such as p53 and NF-kappa B, disrupt hormonal signaling, and overload detoxification systems — weakening immune surveillance and reducing the effectiveness of chemotherapy, immunotherapy, and targeted treatments.Because complete avoidance is impossible in a plastic-saturated world, this episode explains why reducing total toxic burden is essential for healing. Dr. Prato outlines the only clinically applied method currently available to help remove microplastics, heavy metals, and inflammatory signaling from the bloodstream, allowing immune function to recover and cancer therapies to work more effectively.🎯 What You’ll Learn in This Episode:How microplastics accumulate inside human tissueWhy microplastics act as toxin carriers, not passive particlesThe link between chronic inflammation, immune suppression, and cancerHow microplastics interfere with p53, apoptosis, and tumor controlWhy toxic load increases treatment resistance and side effectsWhy detoxification must accompany cancer therapyHow selective plasma exchange can reduce inflammatory burdenPractical steps to minimize ongoing microplastic exposure📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at:https://www.scirp.org/journal/paperinformation?paperid=132493

What if your cancer didn’t begin as bad luck in your DNA — but was fueled by hidden infections your doctors never tested for?In this episode of Outsmart Cancer, Dr. Dino Prato explains how chronic, undiagnosed infections can weaken the immune system, drive inflammation, disrupt tumor-suppressor pathways, and make cancer more aggressive and resistant to treatment.While global estimates suggest about 13% of cancers are linked to infections, Dr. Prato’s clinical experience over more than 25 years shows the number may be far higher — largely because most patients are never thoroughly tested. Viruses, bacteria, parasites, mold toxins, and tick-borne infections can persist silently in the body, suppressing immunity long before cancer develops.Dr. Prato breaks down the three primary ways infections contribute to cancer: direct oncogenic interference with tumor-suppressor genes like p53, genomic instability caused by viral integration, and chronic inflammation that fuels tumor growth and immune exhaustion. He also explains how infections disrupt mitochondrial signaling, impair natural killer cell function, and interfere with modern treatments — including immunotherapy.This episode highlights why eliminating infections and restoring immune function must be part of precision oncology. Without addressing these hidden drivers, even the most advanced cancer therapies may fail to reach their full effectiveness.🎯 What You’ll Learn in This Episode:Why infections are an overlooked contributor to cancerHow viruses like HPV, EBV, and hepatitis affect tumor-suppressor genesThe role of chronic inflammation and immune exhaustionWhy infections increase treatment resistance and immune evasionHow mitochondrial dysfunction impacts cancer immunityWhy deep infectious disease testing is essentialHow eliminating infections can improve treatment response📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Cancer treatment works best when the immune system is no longer under attack.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at:https://www.scirp.org/journal/paperinformation?paperid=132493

If you’ve been told you have a KRAS mutation — or another so-called “undruggable” cancer gene — you may have been placed on a specialty inhibitor designed to slow the disease. And these drugs can be helpful. But there’s a critical truth most patients are never told:Most targeted cancer drugs are cytostatic, not cytotoxic.They slow cancer down — they don’t eliminate it.In this episode of Outsmart Cancer, Dr. Dino Prato explains why drugs targeting KRAS, BRAF, EGFR, MET, HER2, and similar pathways often create a temporary “honeymoon period.” Like unplugging a Christmas tree, the tumors dim — but once the drug stops working, the cancer lights back up.The key question becomes: What are you doing with the time these drugs buy you?Dr. Prato walks through how precision oncology uses that window to activate the immune system. By combining full DNA sequencing, RNA transcriptomics, immune spatial biology, and deep pathway mapping, doctors can identify thousands of targets — not just one mutation. This allows precision combinations, off-label strategies, phytotherapeutics, and direct-to-tumor immunotherapy delivery to expose cancer antigens, release DAMPS, and train natural killer and dendritic cells to eliminate disease system-wide.Instead of waiting for resistance, this approach turns cytostatic slowdown into cytotoxic immune control, even in patients labeled MSS or “not candidates” for standard immunotherapy.🎯 What You’ll Learn in This Episode:• Why KRAS and similar inhibitors slow cancer but rarely eliminate it• The difference between cytostatic and cytotoxic cancer treatment• Why specialty drugs create a critical treatment window• How RNA transcriptomics reveals escape pathways beyond DNA mutations• Why immune spatial biology is essential for durable response• How direct-to-tumor delivery protects immunity and increases effectiveness• Why PD-1 inhibitors alone are rarely enough• The right questions to ask when your targeted drug stops working📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at:https://www.scirp.org/journal/paperinformation?paperid=132493